RE: Ooooohh yeahhhh12 Dec 2020 17:49
Well Melissa, good question.
I view this specific investment as the most important. If successful, then we are onto something. How big a something depends on the demand.
if it's of benefit to diabetics per se, then that's good news. If it's specific to Covid sufferers with diabetes only, then its more limited. Either way, without knowing what else JN has in the pipeline I see it as the key to getting to 1p.
So, like everyone else, am waiting on a successful result (trials) and what actual scope the treatment can provide.
Mode is currently under 40p, but early days yet and not a massive outlay.
I don't see this as a short termer, but as long as JN is CEO I believe he will work tirelessly to get that SP up to that sort.of level.
If it took 2 years from now to get there and with current SP enabling a 10 million share purchase for 7 grand then the returns are significant, especially if stuck in a s&s ISA etc. For me its a bottom drawer buy.
If you hold more shares than that then even better, its really down to whether you have the patience. I'm no dealer, so when bought I rarely tamper with my purchases believing that the stock Market really does favour the patient.